Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
Fondazione Italiana Linfomi - ETS